Literature DB >> 671242

Physical characterization of erythromycin: anhydrate, monohydrate, and dihydrate crystalline solids.

P V Allen, P D Rahn, A C Sarapu, A J Vanderwielen.   

Abstract

Hot-stage microscopy, thermoanalytical methods, and X-ray powder diffraction were used to demonstrate that crystalline erythromycin dihydrate converts to the crystalline anhydrate via a noncrystalline intermediate. X-ray powder diffraction, IR spectral, thermogravimetric, and differential thermal analyses were used to characterize the monohydrate material. The flow interrupt technique, a procedure recently developed to deal with low surface area samples, was employed successfully in obtaining isotherms and specific surface areas for the monohydrate and anhydrate. The relative dissolution rates of the various hydrates were determined in an aqueous solution (0.01 M phosphate buffer, pH 7.5) at 37 degrees. The results showed a significant difference in the dissolution rate of the dihydrate compared to the monohydrate and anhydrate.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 671242     DOI: 10.1002/jps.2600670816

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Influence of crystal habit on trimethoprim suspension formulation.

Authors:  A K Tiwary; G M Panpalia
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

2.  Amphiphilic erythromycin-lipoamino acid ion pairs: characterization and in vitro microbiological evaluation.

Authors:  Rosario Pignatello; Annalisa Mangiafico; Barbara Ruozi; Giovanni Puglisi; Pio Maria Furneri
Journal:  AAPS PharmSciTech       Date:  2011-04-09       Impact factor: 3.246

3.  Improved pharmacokinetics of mercaptopurine afforded by a thermally robust hemihydrate.

Authors:  Kortney M Kersten; Adam J Matzger
Journal:  Chem Commun (Camb)       Date:  2016-03-22       Impact factor: 6.222

4.  Navigating the Waters of Unconventional Crystalline Hydrates.

Authors:  Doris E Braun; Lien H Koztecki; Jennifer A McMahon; Sarah L Price; Susan M Reutzel-Edens
Journal:  Mol Pharm       Date:  2015-06-30       Impact factor: 4.939

5.  Drug solubility: importance and enhancement techniques.

Authors:  Ketan T Savjani; Anuradha K Gajjar; Jignasa K Savjani
Journal:  ISRN Pharm       Date:  2012-07-05

Review 6.  Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs.

Authors:  Roberta Censi; Piera Di Martino
Journal:  Molecules       Date:  2015-10-15       Impact factor: 4.411

7.  Mechanochemical Formation of Racemic Praziquantel Hemihydrate with Improved Biopharmaceutical Properties.

Authors:  Debora Zanolla; Dritan Hasa; Mihails Arhangelskis; Gabriela Schneider-Rauber; Michele R Chierotti; Jennifer Keiser; Dario Voinovich; William Jones; Beatrice Perissutti
Journal:  Pharmaceutics       Date:  2020-03-23       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.